Health Care/Hospital
EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
GENEVA, June 27, 2026 /PRNewswire/ -- Adults with both epilepsy and hearing loss who use hearing aids may have a 23% lower risk of developing dementia than those who do not, according to new research presented at the European Academy of Neurology (EAN) Congress 2026. Hearing loss is widely recog...
2026-06-27 06:01
1459
Frost & Sullivan Institute Honors Organizations Driving Transformative Impact Through Visionary Leadership
SILICON VALLEY, Calif., June 27, 2026 /PRNewswire/ -- The Frost & Sullivan Institute is proud to announce the recipients of the 2026 Visionary Growth Leadership Best Practices Recognition, honoring organizations that are setting new benchmarks for business leadership by tackling some of the world...
2026-06-27 02:30
1740
Key Milestone Achieved: NDA for Sumecigrel Capsule, an Antiplatelet Innovative Drug by Vcare PharmaTech, Officially Accepted
NANJING, China, June 26, 2026 /PRNewswire/ -- Recently, the NDA for Sumecigrel Capsule (formerly known as Vicagrel), a Class 1 innovative antiplatelet drug developed by Jiangsu Vcare PharmaTech Co.,Ltd. (Vcare PharmaTech), has been officially accepted by the NMPA. The drug has now entered the NDA...
2026-06-26 22:30
1861
CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union
* Recommendation follows an Article 20 non-pharmacovigilance procedure * Patients currently on TAVNEOS treatment should consult their treating physician ST. GALLEN, Switzerland, June 26, 2026 /PRNewswire/ -- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and CSL announced today that the...
2026-06-26 21:06
1710
NYSE Content Update: Doncasters Shares Jump 42% in NYSE Trading Debut
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, June 26, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...
2026-06-26 20:59
1709
Merz Aesthetics Launches Ultherapy Mask - PDRN Peptide Radiance in Malaysia and Appoints Scha Alyahya as the First Ultherapy PRIME Brand Ambassador
* Ultherapy Mask - PDRN Peptide Radiance now available in Malaysia exclusively through PRIMEcertified clinics * The at-home mask is designed to support hydration, skin recovery, and overall radiance after Ultherapy PRIME treatment * Scha Alyahya named Malaysia's first Ultherapy PRIME Brand A...
2026-06-26 16:49
803
Beyond Injections: S-CELL Unveils Breakthrough "Endogenous GLP-1" Formula Powered by Akkermansia P9 Signaling and CoreBiome® Technology
HONG KONG, June 26, 2026 /PRNewswire/ -- S-CELL, a premier innovator in cellular health and anti-aging biotechnology, today announced the launch of its advanced metabolic support synbiotic (Prebiotic and Probiotic) supplement. This pioneering formula represents a paradigm shift in weight manageme...
2026-06-26 14:42
1159
Radisson Hotel Group shapes the future of healthcare meeting design
New industry report by Radisson Hotel Group highlights the shift from event execution to strategic healthcare meeting design, underpinned by methodology, intelligent orchestration, and measurable outcomes. BRUSSELS, June 26, 2026 /PRNewswire/ -- Radisson Hotel Group (RHG) is helping drive a new ...
2026-06-26 14:41
943
State Grid Anding District Power Supply Company (Dingxi City): Power Safeguards a New Medical Hub
DINGXI, China, June 26, 2026 /PRNewswire/ -- On June 23, State Grid Gansu Dingxi Anding District Power Supply Company successfully completed the acceptance and power transmission of the power receiving project for the Xichuan New Campus of Dingxi Hospital Affiliated to Changchun University of Ch...
2026-06-26 14:01
1138
Everest Medicines Announces China NMPA Acceptance of the Biologics License Application for LEROCHOL® in Adults with Hypercholesterolemia
SHANGHAI, June 26, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that China's National Medical Products...
2026-06-26 10:08
942
Dr.Look Ai helps families cut kids' passive screen time
Two-Time International Design Award Winner Dr.Look Ai Donates AI Learning Cameras to Two Children's Hospitals, Tackling North American Parenting Challenges Through Real-World Exploration BOSTON, June 25, 2026 /PRNewswire/ -- Dr.Look Ai, a children's technology brand and two-time international de...
2026-06-26 09:45
942
NextRise 2026, Seoul Successfully Wraps Up as Asia's Leading Startup Fair Co-hosted by KITA and KDB
SEOUL, South Korea, June 26, 2026 /PRNewswire/ -- The Korea International Trade
Association (KITA) and Korea Development Bank (KDB) successfully wrapped up
NextRise 2026, Seoul, Asia's leading startup fair, at COEX in Samseong-dong,
Seoul, after a two-day run from June 18 to 19, 2026.
2026-06-26 08:00
986
The 4th China International Supply Chain Expo: Healthy Life Chain Unveils Full Spectrum of Global Healthcare Supply Chain Innovation
BEIJING, June 26, 2026 /PRNewswire/ -- The Fourth China International Supply Chain Expo (CISCE) has opened its Healthy Life Chain section, drawing more than 100 leading companies across three core zones—Medical Technology, Quality Living, and Heritage Wellness. Together, they present digital and ...
2026-06-26 03:33
1120
Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts international conference on complex cardiac arrhythmias
EPLive 2026 included 1,600 of the world's top cardiac electrophysiology experts AUSTIN, Texas, June 26, 2026 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its eighth international symposium on complex arrhythmias on May 28-29, 2026. This year's...
2026-06-26 02:55
836
Racura Oncology Doses First Patient in Phase 1 HARNESS-1 Trial of RC220 in EGFR-Mutant Non-Small Cell Lung Cancer
Racura Oncology has dosed the first patient in the HARNESS-1 Phase 1a/b trial of RC220 in combination with osimertinib for EGFR-mutant non-small cell lung cancer. The study will assess safety, pharmacokinetics, ctDNA dynamics and early clinical activity of RC220 as a strategy to address therapeut...
2026-06-25 22:51
1161
ROYAL CARIBBEAN PARTNERS WITH ROALD DAHL'S MARVELLOUS CHILDREN'S CHARITY AHEAD OF "CHARLIE AND THE CHOCOLATE FACTORY" DEBUT ON LEGEND OF THE SEAS
The partnership will raise funds for specialist children's nurses through onboard donations and awareness initiatives during the new Icon Class ship's inaugural European season in July 2026 LONDON, June 25, 2026 /PRNewswire/ -- Royal Caribbean today announced a new partnership withRoald Dahl's M...
2026-06-25 22:08
1235
FIT KING Highlights How Different Consumer Routines Are Shaping At-Home Recovery Needs
The wellness brand outlines how its at-home recovery lineup matches active lifestyles, busy workdays, travel routines, first-time users, and everyday home wellness needs NEW YORK, June 25, 2026 /PRNewswire/ -- As recovery continues to move beyond elite athletics and into everyday wellness, FIT K...
2026-06-25 21:00
828
Axtria Ignite 2026: 450+ Life Sciences Leaders Convene With a Contrarian Message -- Fix the Foundation Before You Scale AI
* More than 450 executives from 100+ leading life sciences organizations gathered in Princeton, NJ to move agentic AI past the proof-of-concept stage * Founder and CEO Jaswinder "Jassi" Chadha challenged the industry with a counterintuitive mandate: before you build more agents, fix the founda...
2026-06-25 20:15
1007
Zhongchao Inc. Announces 1-for-3 Share Consolidation
SHANGHAI, June 25, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-3 share consolidation of...
2026-06-25 20:00
1369
CStone Pharmaceuticals Enters into Exclusive Commercialization Agreement with Arrotex for Sugemalimab across Australia and New Zealand
* Arrotex, the pharmaceutical commercialization platform of DBG, Australia's leading diversified healthcare group, will be responsible for the registration, market access, and commercialization of sugemalimab in Australia and New Zealand. * This partnership marks sugemalimab's fifth internati...
2026-06-25 17:44
843
Week's Top Stories
Most Reposted
Vietnam Explores Sustainable Aviation Fuel Development at International Conference in Hanoi
[Picked up by 301 media titles]
2026-06-25 14:33
MetaOptics Begins Shipment of Metalens Smartphone and AI Smart Glasses to European and Japanese Customers for Evaluation
[Picked up by 300 media titles]
2026-06-26 18:11IPD and ABB Help Power Sustainable Operations at New Sydney Fish Market
[Picked up by 298 media titles]
2026-06-22 17:40
SPHERE AX Partners with U.S. AI Semiconductor Company Blaize at the National Assembly
[Picked up by 293 media titles]
2026-06-24 18:00
BELLUSTAR TOKYO Ranked No. 10 Among Japan's Best City Hotels in Prestigious Award Chosen by Asia-Pacific Travelers
[Picked up by 290 media titles]
2026-06-24 12:00
Most Read
National Book Store Partners with Anchanto to accelerate success across Online Channels & 260+ Retail Locations
2026-06-23 08:00
2920
IBM and OpenAI Bring Frontier AI to Cyber Defense--Helping Enterprises Keep Pace with Machine-Speed Threats
2026-06-23 05:18
2720
